Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012)

Opko Health's (OPK) quarterly Cash from Discontinued Operations came in at -$7000.0 in Q4 2012, up 97.51% on a YoY basis from -$3544.1 in Q1 2012, and down 107.29% quarter-over-quarter from $96000.0 in Q3 2012.

Analysis

Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012) Analysis & Trends

Opko Health (OPK) has reported Cash from Discontinued Operations for 3 consecutive years, with -$7000.0 the latest figure, recorded in Q4 2012.

  • For the quarter ending Q4 2012, Cash from Discontinued Operations rose 97.51% year-over-year to -$7000.0; the trailing twelve-month figure through Dec 2013 stood at $89000.0 (up 1171.43% YoY), and the FY2012 full-year result was $7000.0, up 100.15% from the prior year.
  • Cash from Discontinued Operations retreated to -$7000.0 in Q4 2012 per OPK's latest filing, from $96000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at $96000.0 in Q3 2012 and bottomed at -$1.6 million in Q3 2011.
  • Historically, Cash from Discontinued Operations has averaged -$575555.6 across 3 years, with a median of -$281000.0 in 2011.
  • The sharpest annual moves came in 2011 and 2012: Cash from Discontinued Operations jumped 55.11% in 2011, then jumped 106.04% in 2012.
  • Over 3 years, Cash from Discontinued Operations stood at -$626000.0 in 2010, then surged by 55.11% to -$281000.0 in 2011, then surged by 97.51% to -$7000.0 in 2012.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods registered -$7000.0, $96000.0, and -$157000.0 for Q4 2012, Q3 2012, and Q2 2012 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -7,000.00
Sep 30, 2012 96,000.00
Jun 30, 2012 -157,000.00
Mar 31, 2012 75,000.00
Dec 31, 2011 -281,000.00
Sep 30, 2011 -1.59 Mn
Jun 30, 2011 -1.11 Mn
Mar 31, 2011 -1.59 Mn
Dec 31, 2010 -626,000.00
API Access

Opko Health Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=OPK&period=max&api_key=YOUR_API_KEY